United Therapeutics (UTHR) Excise tax on net share repurchase — Quarterly & Annual

Screener

Excise tax on net share repurchase at other companies

CHE

ChemedCHE

-$1.92M—

CHE

ChemedCHE

-$1.92M—

BK

BKBK

$6M-7.7%

PultegroupPHM

$2.89M+19.2%

CRA InternationalCRAI

$270K-36.8%

CRA InternationalCRAI

$270K-36.8%

Other financials

Income statement

Revenue$783.3M-1.9%

Gross profit$683.8M-3.8%

Operating income$330.8M-9.2%

Net income$333.0M+7.6%

EPS (diluted)$7.27+13.4%

Balance sheet

Cash & equivalents$1.8B+13.2%

Total debt$12.2M—

Total equity$6.4B-10.8%

Total assets$7.2B-8.7%

Cash flow

Operating cash flow$313.6M+63.6%

CapEx$108.0M+73.6%

Free cash flow$205.6M+58.8%

Valuation

Market cap$22.86B+67.1%

P/E17.4×+6.4×

P/S7.3×+2.8×

Profitability

Gross margin86.1%-2.8pp

Operating margin44.4%-2.6pp

Net margin41.6%+1.2pp

FCF margin34.6%-0.1pp

Returns & leverage

Return on equity19.3%0.0pp

Debt / equity0×—

Current ratio5.7×-1.5×

Where this comes from

Reported directly by United Therapeutics in its filing.

Tagged under the XBRL concept uthr:NoncashExciseTaxOnNetShareRepurchases.

The source filing: United Therapeutics’s 10-Q, filed May 6, 2026. Open the filing →

Filed: May 6, 2026, 6:30 AM EDT
Fiscal quarter: Q1 FY2026
Calendar quarter: Q1 2026
Accession: 0001082554-26-000020

FAQ

What is United Therapeutics's excise tax on net share repurchase?: United Therapeutics (UTHR) reported excise tax on net share repurchase of $8.4M in Q1 2026.
What does excise tax on net share repurchase mean?: Excise tax on net share repurchase as reported by United Therapeutics Corp.

Ask your AI about United Therapeutics's excise tax on net share repurchase.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk